Evaluation of a microassay for human kininogens as cysteine protease inhibitors.
Several methods have been described for the identification and quantification of kininogens based on both immunochemical and functional characteristics. This article presents a rapid, cheap and simple microplate assay of kininogens based on their ability to inhibit cysteine proteases. The target enzyme papain is activated by cysteine HCl and the activated enzyme will be inhibited by added kininogens. The residual enzyme activity that is not inhibited in this reaction subsequently hydrolyzes the added substrate, S-2302, generating a yellow color that is read in a microplate reader at 405 nm. This method is very sensitive, the smallest amount of kininogen that causes significant inhibition of papain is established to be 0.01 micrograms. As a quantitative method, the assay performs accurately when approximately 0.1 micrograms of low molecular weight kininogen or high molecular weight kininogen is added to the test system. The within-run coefficient of variation (%) of the method was 1.7% when the inhibition of papain was in the range 45-70% and the day to day variation as low as 2.3% when performed with a papain inhibition of 80%. Applications of the method are presented, studying chromatographic separated kininogens in plasma, ascites, and urine.
Karlsrud
T S
TS
Department of Pharmacology, University of Oslo, Norway.
Aasen
A O
AO
Johansen
H T
HT
D001201:Ascites / Q000378:metabolism; D002863:Chromogenic Compounds; D015853:Cysteine Proteinase Inhibitors / Q000032:analysis* / Q000494:pharmacology; D006801:Humans; D007704:Kininogens / Q000032:analysis* / Q000494:pharmacology; D010206:Papain / Q000037:antagonists & inhibitors
D002863:Chromogenic Compounds; D015853:Cysteine Proteinase Inhibitors; D007704:Kininogens; D010206:Papain